RNase 3 (1-45) [C23,37S; R1,7,22,28,34,36,38,45K]

General Information


DRACP ID  DRACP03904

Peptide Name   RNase 3 (1-45) [C23,37S; R1,7,22,28,34,36,38,45K]

Sequence  KPPQFTKAQWFAIQHISLNPPKSTIAMKAINNYKWKSKNQNTFLK

Sequence Length  45

UniProt ID  P12724 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C246H382N66O62S

Absent amino acids  CDEGRV

Common amino acids  K

Mass  607320

Pl  11.3

Basic residues  9

Acidic residues  0

Hydrophobic residues  15

Net charge  9

Boman Index  -6976

Hydrophobicity  -81.78

Aliphatic Index  60.89

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  12490

Absorbance 280nm  283.86

Polar residues  12

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31540052

Title  Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  14152

DRACP is developed by Dr.Zheng's team.